Cargando…
Effectiveness and safety of four different beta‐blockers in patients with chronic heart failure
In this study, we evaluated the effectiveness and safety of bisoprolol, metoprolol, carvedilol, and nebivolol in the treatment of chronic heart failure. The results demonstrated that bisoprolol improved the prognosis of chronic heart failure in comparison with carvedilol, and carvedilol exerted simi...
Autores principales: | Liu, Baoshan, Zhang, Rui, Zhang, Aiyuan, Wang, Guodong, Xu, Jiupan, Zhang, Yun, Liu, Yanping, Hao, Panpan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9823244/ https://www.ncbi.nlm.nih.gov/pubmed/36628295 http://dx.doi.org/10.1002/mco2.199 |
Ejemplares similares
-
Is heart rate reduction more important than target dose in chronic heart failure therapy with a beta-blocker?
por: Guo, Yong-Fang, et al.
Publicado: (2011) -
Disease-modifying medications in heart failure: more than ACE inhibitors and beta blockers
por: Chao, Chia-Ter
Publicado: (2011) -
Editorial: Fibrosis: etiology, pathophysiology, measurements, and therapy
por: Liu, Yanping, et al.
Publicado: (2023) -
Treatment optimization of beta-blockers in chronic heart failure therapy
por: Niriayo, Yirga Legesse, et al.
Publicado: (2020) -
Beta-Blockers and Oxidative Stress in Patients with Heart Failure
por: Nakamura, Kazufumi, et al.
Publicado: (2011)